company background image
524703 logo

Sandu Pharmaceuticals BSE:524703 Stock Report

Last Price

₹72.19

Market Cap

₹697.4m

7D

-4.2%

1Y

17.4%

Updated

25 Feb, 2024

Data

Company Financials

Sandu Pharmaceuticals Limited

BSE:524703 Stock Report

Market Cap: ₹697.4m

524703 Stock Overview

Sandu Pharmaceuticals Limited manufactures and markets ayurvedic medicines under the SANDU brand in India and internationally.

524703 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends2/6

Sandu Pharmaceuticals Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sandu Pharmaceuticals
Historical stock prices
Current Share Price₹72.19
52 Week High₹85.00
52 Week Low₹49.00
Beta0.65
1 Month Change2.70%
3 Month Change7.03%
1 Year Change17.38%
3 Year Change131.38%
5 Year Change211.84%
Change since IPO862.53%

Recent News & Updates

Recent updates

Shareholder Returns

524703IN Personal ProductsIN Market
7D-4.2%0.4%0.9%
1Y17.4%7.1%48.1%

Return vs Industry: 524703 exceeded the Indian Personal Products industry which returned 7.1% over the past year.

Return vs Market: 524703 underperformed the Indian Market which returned 48.1% over the past year.

Price Volatility

Is 524703's price volatile compared to industry and market?
524703 volatility
524703 Average Weekly Movement4.0%
Personal Products Industry Average Movement4.2%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.7%
10% least volatile stocks in IN Market3.8%

Stable Share Price: 524703 has not had significant price volatility in the past 3 months.

Volatility Over Time: 524703's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1899323Umesh Sanduhttps://sandu.in

Sandu Pharmaceuticals Limited manufactures and markets ayurvedic medicines under the SANDU brand in India and internationally. The company offers sandu mahasudarshan kadha no 1, sandu abhayarishta, sandu pathyadi kadha, sandu makarprash, sandu gulkand pravalyukta, sandu acivin herbal antacid, sandu ashwagandharishta, sandu amritarishta, sandu hemocleen excellent blood purifier, and sandu vanari granules. It also provides mahasudarshan kadha, amritarishta, tab.

Sandu Pharmaceuticals Limited Fundamentals Summary

How do Sandu Pharmaceuticals's earnings and revenue compare to its market cap?
524703 fundamental statistics
Market cap₹697.43m
Earnings (TTM)₹11.38m
Revenue (TTM)₹669.48m

61.3x

P/E Ratio

1.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
524703 income statement (TTM)
Revenue₹669.48m
Cost of Revenue₹346.86m
Gross Profit₹322.62m
Other Expenses₹311.24m
Earnings₹11.38m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)1.18
Gross Margin48.19%
Net Profit Margin1.70%
Debt/Equity Ratio0%

How did 524703 perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

47%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.